Saunder Bernes
Neurology with Special Qualifications in Child Neurology · Phoenix, AZNPI 1700848868
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Sarepta Therapeutics, Inc. at 48.0% of the total. Reporting peaked in 2023 at $10,352 and has fallen 58.6% since, to $4,288 in 2025. Among neurology with special qualifications in child neurology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $386.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$13K
- Genentech USA, Inc.$6K
- UCB, Inc.$3K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$3K
- CSL Behring$600
- Biogen$256
- plus $577 from 8 others
Across 232 payments — averaging $2898.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$226K
- PTC Therapeutics, Inc.$140K
- Janssen Research & Development, LLC$126K
- Novartis$70K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$47K
- Genentech, Inc.$43K
- plus $20K from 2 others
What the payments were for
- Consulting fees$15,89058%
- Speaking & faculty fees$8,79232%
- Travel & lodging$1,0924%
- Food & beverage$1,3285%
- Education$3391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 17 | $13,163 |
| Genentech USA, Inc. | 4 | $6,080 |
| UCB, Inc. | 3 | $3,448 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 8 | $3,317 |
| CSL Behring | 1 | $600 |
| Biogen | 7 | $256 |
| PTC Therapeutics, Inc. | 8 | $206 |
| ITF Therapeutics LLC | 4 | $174 |
| Johnson & Johnson | 2 | $55 |
| Sumitomo Pharma America, Inc. | 4 | $47 |
| NS Pharma, Inc. | 2 | $34 |
| Travere Therapeutics, Inc. | 9 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVRYSDI$6,080
- Exondys 51$5,192
- ZOLGENSMA$3,142
- Privigen$600
- EMFLAZA$128
How this compares
$27,441 in reported general payments places this provider in the 90th percentile of 49 neurology with special qualifications in child neurology providers in Arizona.
See all neurology with special qualifications in child neurology providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EvrysdiRisdiplam | 14 | $369,068 |
| CarbatrolCarbamazepine | 12 | $2,600 |
| Levetiracetam | 53 | $1,559 |
| Lamotrigine | 13 | $223 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Genentech USA, Inc.Evrysdi | $6,080 | $369,06814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 49 neurology with special qualifications in child neurology providers in Arizona.
Other neurology with special qualifications in child neurology in Phoenix
- Angus WilfongPhoenix$348K
- Clara ChowPhoenix$35K
- Randa JarrarPhoenix$25K
- Jeffrey BuchhalterPhoenix$19K
- Korwyn WilliamsPhoenix$13K
- Harlori BainsPhoenix$12K
- Tamara ZachPhoenix$10K
- Javier CardenasPhoenix$6K
- Vinodh NarayananPhoenix$5K
- Richard FryePhoenix$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.